Author:
Valesky Eva M.,McKay Sue,van Oosterhout Antoon J. M.,Parnham Michael J.
Publisher
Springer International Publishing
Reference4 articles.
1. Carr WW, Nelson MR, Hadley JA. Managing rhinitis: strategies for improved patient outcomes. Allergy Asthma Proc. 2008;29:349–57.
2. Hill SJ, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM, Schunack W, Levi R, Haas HL. International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev. 1997;49:253–78. (see also:
http://pharmrev.aspetjournals.org/cgi/reprint/49/3/253
. Accessed Sept 2010).
3. Holgate S, Buhl R, Bousquet J, Smith N, Panahloo Z, Jimenez P. The use of omalizumab in the treatment of severe allergic asthma: a clinical experience update. Respir Med. 2009;103:1098–113.
4. Lieberman P. Intranasal antihistamines for allergic rhinitis: mechanism of action. Allergy Asthma Proc. 2009;30:345–8.